HTS approaches to voltagegated ion channel drug discovery

Drug Discovery Today

Volumn 3, Issue 7, 1998, Pages 323-332

  Denyer, Jane ^a   Worley, Jennings ^b   Cox, Brian ^a   Allenby, Gary ^a   Martyn Banks, ^a  

^a GLAXOSMITHKLINE   (United Kingdom)

^b GLAXOSMITHKLINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ION CHANNEL;

CELL VIABILITY; CONFORMATIONAL TRANSITION; DEVICE; DRUG INDUSTRY; DRUG SCREENING; ELECTROPHYSIOLOGY; LIGAND BINDING; PATCH CLAMP; REVIEW; SCINTILLATION CAMERA;

EID: 0344222200     PISSN: 13596446     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1359-6446(98)01199-4     Document Type: Article

References (33)

1. Goldin, S.M. (1997) D and MD Report No. 909 (Vol. 4) IBC.
2. Hille, B. (1992) Ionic Channels of Excitable Membranes (2nd edn), Sinauer Associates.
3. North, R.A., ed. (1995) Ligand- and Voltage-gated Ion Channels, CRC Press.
4. Catterall W.A. Annu. Rev. Biochem. 64:1995;495-531.
5. Catterall W.A., Trainer V., Baden D.G. Bull. Soc. Path. Exp. 85:1992;481-485.
6. Catterall W.A. Trends Pharmacol. Sci. 13:1987;256-262.
7. Xie X.et al. Pflügers Arch. 430:1995;437-446.
8. Strichartz G., Rando T., Wang G.K. Annu. Rev. Neurosci. 10:1987;237-267.
9. Narahashi T., Harman M. Methods Enzymol. 207:1992;620-643.
10. Schroeder K.S., Neagle B.D. J. Biomol. Screening. 2:1996;75-80.
11. Epps D.E.et al. Chem. Phys. Lipids. 69:1994;137-150.
12. Willow M., Kuenzel E.A., Catterall W.A. Mol. Pharmacol. 25:1984;228-234.
13. Reith M.E. Eur. J. Pharmacol. 188:1990;33-41.
14. Ichida S.et al. Jpn J. Pharmacol. 64:1994;209-212.
15. de-Allie F.A.et al. Br. J. Pharmacol. 117:1996;479-487.
16. Anon. (1996) Cytostar-T Scintillating Microplate: A Basic Guide, Proximity News Issue No. C1, Amersham Life Science.
17. Kogure K.et al. Toxicon. 26:1988;191-197.
18. Manger R.L.et al. Anal. Biochem. 214:1993;190-194.
19. Anderson J.A., Nakamura R.L., Gaber R.F. Symp. Soc. Exp. Biol. 48:1994;85-97.
20. Jellett J.F.et al. Toxicon. 30:1992;1143-1156.
21. Hamill O.P. Pflügers Arch. 391:1981;85-100.
22. Olesen, S-P. et al. (1995) Voltage-Gated Ion Channel Modulators, 7-8 December, Philadelphia, PA, USA.
23. Gordeev, M.F. and Patel, D.V. (1996) PCT Int. Appl, WO 9633972.
24. Patel, D.V et al. (1996) Mol. Diversity Comb. Chem. Libr. Drug Discovery, Conf., 28 January-2 February, Coronado, CA, USA, pp. 58-69.
25. Baldwin, J.J. et al. (1995) PCT Int. Appl, WO 9530642.
26. Pavia, M.R. et al. (1995) PCT Int. Appl, WO 9504277.
27. Still, W. et al. (1994) PCT Int. Appl, WO 9408051.
28. Olivera B.M.et al. Trends Biotechnol. 13:1995;422-426.
29. Banks M.et al. J. Biomol. Screening. 2:1997;133-135.
30. Harding D.et al. Drug Discovery Today. 2:1997;385-390.
31. Wilson R.J.et al. J. Neurosci. Methods. 53:1994;101-110.
32. Breckenridge L.J.et al. J. Neurosci. Res. 42:1995;266-276.
33. Cornell B.A.et al. Nature. 387:1997;580-583.